conflict of interest
Cost Cap primary care project only focusing on raising spending, not services
At the October 26th Primary Care Subgroup meeting, in response to questioning by a member, the Office of Health Strategy’s (OHS) consultants repeatedly confirmed that the goal of the Cost Cap provision on primary care is solely to raise spending, not to increase services. Members raised serious concerns about sending more money into the current…
Read MoreNew Cost Cap Steering Committee is industry-driven
The first meeting of the new Steering Committee to guide the Office of Health Strategy’s (OHS) plan to cap healthcare cost growth was uncharacteristically quiet. The meeting started with public comment from the Universal Healthcare Foundation of CT that the committee membership is “not balanced”, includes mainly members with “deep vested business interests”, and lacks…
Read MoreSign on letter voices deep concerns with primary care capitation
Today twenty-five independent advocates and providers signed a letter to the Office of Health Strategy opposing capitation of primary care services across Connecticut. The letter shares serious concerns with the Office of Health Strategy’s (OHS) plan to shift all primary care in Connecticut to a capitated payment model. The current concerns echo advocates’ and legislators’…
Read MoreCTNJ: OP-ED | Legislators Hear How RI Saved 2 Hospitals From Private Equity, Other Solutions to High Insurance Premiums
On Friday, in a forum sponsored by state Rep. Kerry Wood, six national and local experts gave legislators specific policy tools to help with health care market consolidation and rising drug prices that are driving up health insurance premiums. Legislators also got specific tools used by Rhode Island to avoid private equity abuses experienced in…
Read MoreCTNJ: Insulin – Once a Gift, Now Serving Greed
Today is the hundredth anniversary of the discovery of insulin. Diabetes affects about 367,000 adults in Connecticut and that number is rising. Before the 1920s, a diabetes diagnosis was a death sentence. The discovery of insulin allowed people with diabetes to live their lives. Until the 1970s insulin was affordable, but it’s now so costly…
Read MoreGood and bad Medicaid PCMH, PCMH Plus updates
At today’s MAPOC Care Management Committee, we learned that Medicaid’s successful Patient-Centered Medical Home (PCMH) program is growing and keeping up with higher enrollment due to COVID. In disappointing news, we also learned that the controversial PCMH Plus program has fewer care managers than expected and only 36% of ACO member advisory committees have any…
Read MoreBook Club: Medical Apartheid
Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present is very difficult to read. I stopped and re-started several times. You may know something about the Tuskegee syphilis project, but the wanton use and abuse of Black Americans as medical subjects goes much farther and continues into…
Read MoreCT physician earns Shkreli award overcharging for COVID tests
Dr. Steven Murphy, a Greenwich internist, has earned a 2020 Shkreli Award from the Lown Institute. Dr. Murphy earned the award for overcharging at several town COVID testing sites he ran for several towns including New Haven. He overcharged thousands for “super Covid tests” and other unnecessary tests. He charged $480 for a 30-second phone…
Read MoreNew Medicaid homelessness prevention program shows promise
Starting August 1st, Medicaid members at risk of homelessness will have access to housing support services and subsidies through the new CHESS program. The program is designed to address upstream problems to prevent future problems and improve overall health. Described at today’s MAPOC meeting, the plan expects to serve about 850 Medicaid members with care…
Read MoreBOOK CLUB — The Right Price: A Value-Based Prescription for Drug Costs
For your summer reading. The Right Price: A Value-Based Prescription for Drug Costs offers the best explanation I’ve found of how drug costs are set, and how they should be. Using real-life patient stories, the authors give a balanced and comprehensive look at fair and reasonable pricing for a product that epitomizes market failure. The…
Read More